Ultragenyx Pharmaceutical(CH:UP0)
CHF 13.51+0.07 (+0.48%)
CH:UP0
Ultragenyx Pharmaceutical earnings date
CHF 13.51
At close:+0.07 (+0.48%)
Ultragenyx Pharmaceutical (UP0) Q2 2024 Earnings Report
0 Followers
CH:UP0 Q2 2024 EPS Results
- Actual EPS
- -CHF 1.28
- Consensus EPS
- -CHF 1.40
- Beat/Miss
- Beat by +CHF 0.12
- One Year Ago EPS
- -CHF 1.89
CH:UP0 Q2 2024 Revenue Results
- Actual Revenue
- CHF 123.61M
- Expected Revenue
- CHF 103.58M
- Beat/Miss
- Beat by +CHF 20.03M
- YoY Revenue Growth
- +35.75%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/01/2024
- Time
- After Close
- Conference Call
- Thursday, August 1, 2024
CH:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
CH:UP0 Q2 2024 Earnings Call
0:00 / 0:00
Q2 2024 Earnings Slide Deck
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 1.99- | -1.08 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.92-0.98 | -1.52 | 35.91% (+0.55) | |
| Aug 04, 2026 | 2026 (Q2) | -1.04-0.76 | -0.98 | 23.08% (+0.23) | |
| May 05, 2026 | 2026 (Q1) | -1.25-1.55 | -1.32 | -17.20% (-0.23) | |
| Feb 12, 2026 | 2025 (Q4) | -0.92-1.08 | -1.17 | 7.19% (+0.08) | |
| Nov 04, 2025 | 2025 (Q3) | -1.04-1.52 | -1.18 | -29.29% (-0.34) | |
| Aug 05, 2025 | 2025 (Q2) | -1.09-0.98 | -1.28 | 23.03% (+0.29) | |
| May 06, 2025 | 2025 (Q1) | -1.34-1.32 | -1.71 | 22.66% (+0.39) | |
| Feb 13, 2025 | 2024 (Q4) | -1.10-1.17 | -1.28 | 8.55% (+0.11) | |
| Nov 05, 2024 | 2024 (Q3) | -1.25-1.18 | -1.87 | 37.22% (+0.70) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


